Company intelligence / Profile preview

Sound Life Sciences

Seattle, Washington, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Sound Life Sciences developed a proprietary contactless software application using sonar on smartphones and smart speakers to monitor breathing; their app was FDA-cleared and demonstrated effectiveness in clinical testing for both simulated and real-world opioid overdose scenarios

Therapeutic areas: CardiovascularInfectious DiseasesPulmonologyNeurology
Modalities: Device (software-as-medical-device)
Industry: Digital Health Medical Devices

Partnerships

University of Washington (spinout)NIHBiomedical Advanced Research and Development Authority (funding)

Beyond the preview

Go deeper on Sound Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sound Life Sciences.

Explore the full profile